FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| ProRx | 118230111 | Nicotinamide Adenine Dinucleotide | 1000 mg/10 mL | 2025-2 | source_no_ndc | 2026-10-15 | |||
| ProRx | 118230111 | Nicotinamide Adenine Dinucleotide | 100 mg/1 mL | 2025-2 | source_no_ndc | 2026-10-15 | |||
| ProRx | 118230111 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 150 mg/5 mL; .05 mg/5 mL; 5 mg/5 mL | 2025-2 | source_no_ndc | 2026-10-15 | |||
| ProRx | 118230111 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 150 mg/5 mL; .1 mg/5 mL; 10 mg/5 mL | 2025-2 | source_no_ndc | 2026-10-15 | |||
| Qualgen LLC | 034474862 | 69761-252 | 69761-252-01 | Testosterone | 25 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-372 | 69761-372-01 | Testosterone | 37.5 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-122 | 69761-122-01 | Testosterone | 12.5 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-102 | 69761-102-01 | Testosterone | 100 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-203 | 69761-203-01 | Testosterone | 200 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-502 | 69761-502-01 | Testosterone | 50 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-872 | 69761-872-01 | Testosterone | 87.5 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-202 | 69761-202-01 | Testosterone | 200 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-103 | 69761-103-01 | Testosterone | 100 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-503 | 69761-503-01 | Testosterone | 50 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-873 | 69761-873-01 | Testosterone | 87.5 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-101 | 69761-101-01 | Estradiol | 10 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-151 | 69761-151-01 | Estradiol | 15 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-201 | 69761-201-01 | Estradiol | 20 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-181 | 69761-181-01 | Estradiol | 18 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-061 | 69761-061-01 | Estradiol | 6 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-251 | 69761-251-01 | Estradiol | 25 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-121 | 69761-121-01 | Estradiol | 12.5 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 034474862 | 69761-212 | 69761-212-01 | Anastrozole; Testosterone | 20 mg; 200 mg | 2025-2 | valid | 2026-10-15 | |
| Qualgen LLC | 69761-061 | 69761-061-01 | Estradiol | Estradiol | 6 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-101 | 69761-101-01 | Estradiol / Stearic Acid | Estradiol | 10 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-151 | 69761-151-01 | Estradiol / Stearic Acid | Estradiol | 15 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-201 | 69761-201-01 | Estradiol / Stearic Acid | Estradiol | 20 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-181 | 69761-181-01 | Estradiol / Stearic Acid | Estradiol | 18 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-251 | 69761-251-01 | Estradiol / Stearic Acid | Estradiol | 25 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-121 | 69761-121-01 | Estradiol / Stearic Acid | Estradiol | 12.5 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-503 | 69761-503-01 | Testosterone | Testosterone | 50 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-103 | 69761-103-01 | Testosterone | Testosterone | 100 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-203 | 69761-203-01 | Testosterone | Testosterone | 200 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-873 | 69761-873-01 | Testosterone | Testosterone | 87.5 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-212 | 69761-212-01 | Testosterone / Anastrozole | Testosterone, Anastrozole | 20 mg; 200 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-372 | 69761-372-01 | Testosterone / Stearic Acid | Testosterone | 37.5 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-502 | 69761-502-01 | Testosterone / Stearic Acid | Testosterone | 50 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-202 | 69761-202-01 | Testosterone / Stearic Acid | Testosterone | 200 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-872 | 69761-872-01 | Testosterone / Stearic Acid | Testosterone | 87.5 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-252 | 69761-252-01 | Testosterone / Stearic Acid | Testosterone | 25 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-102 | 69761-102-01 | Testosterone / Stearic Acid | Testosterone | 100 mg | 2025-2 | valid | 2026-09-18 | |
| Qualgen LLC | 69761-122 | 69761-122-01 | Testosterone / Stearic Acid | Testosterone | 12.5 mg | 2025-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-435 | 70092-435-46 | Acetaminophen 10 mg/ml 10 ml syr PF | Acetaminophen 10 mg/ml 10 ml syr PF | 100 mg/10 mL | 2025-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-004 | 70092-004-37 | Amiodarone 450mg add to 250ml D5W IVB | Amiodarone 450mg add to 250ml D5W IVB | 450 mg/250 mL | 2025-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-005 | 70092-005-38 | Amiodarone 900mg add to 500ml D5W IVB | Amiodarone 900mg add to 500ml D5W IVB | 900 mg/500 mL | 2025-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-229 | 70092-229-43 | Atropine 0.4 mg/ml 2.5 ml- 3 ml syr | Atropine 0.4 mg/ml 2.5 ml- 3 ml syr | 1 mg/2.5 mL | 2025-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-475 | 70092-475-50 | Dextrose PF 500mg/ml 50ml SWFI syr | Dextrose PF 500mg/ml 50ml SWFI syr | 25 g/50 mL | 2025-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-575 | 70092-575-36 | Diltiazem PF 125mg in 125ml D5W IVB | Diltiazem PF 125mg in 125ml D5W IVB | 125 mg/125 mL | 2025-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-007 | 70092-007-36 | Diltiazem PF 125mg in 125ml D5W IVB | Diltiazem PF 125mg in 125ml D5W IVB | 125 mg/125 mL | 2025-2 | valid | 2026-09-18 | |
| QuVa Pharma, Inc. | 70092-455 | 70092-455-46 | Ephedrine PF 5 mg/ml in 10 ml NS syr | Ephedrine PF 5 mg/ml in 10 ml NS syr | 50 mg/10 mL | 2025-2 | valid | 2026-09-18 |